-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Nurix Therapeutics, Raises Price Target to $40

Benzinga·07/10/2026 13:30:47
Listen to the news
Stifel analyst Stephen Willey maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price target from $34 to $40.